# Modelling adipose tissue-cancer crosstalk: a three-dimensional perspective

**Authors:** Gabriele Strusi, Caterina M. Suelzu, Justin Stebbing

PMC · DOI: 10.1038/s41388-026-03697-w · Oncogene · 2026-02-18

## TL;DR

This review discusses how 3D models can help study the complex interactions between adipose tissue and cancer, offering a more realistic approach to understanding cancer development linked to obesity.

## Contribution

The paper provides a comprehensive overview of 3D models for studying adipose tissue-cancer interactions, highlighting their potential for pre-clinical research.

## Key findings

- 3D models better mimic in vivo conditions for studying cell interactions.
- Adipose tissue secretes factors that influence carcinogenesis.
- Obesity-related adipose dysfunction is strongly linked to cancer development.

## Abstract

Innovative three-dimensional (3D) systems have become a focus of research due to their ability to better mimic cell-cell and cell-extracellular matrix interactions. Current advances in 3D modelling have the potential to transform pre-clinical research by providing a more biologically relevant recapitulation of the in vivo cell environment. Among the published 3D platforms there is a lack of adipose tissue and cancer complex models. Primarily thought to function in triglyceride storage, protection and heat production, adipose tissue is now recognised as a complex and dynamic endocrine organ that secretes factors such as free fatty acids and adipokines, which have been shown to play a role in carcinogenesis. Obesity, a major cause of adipose tissue dysfunction, has also been strongly linked to the development of several types of cancer. 3D model technologies offer an innovative way to investigate adipose tissue-cancer crosstalk by mimicking in vivo conditions. This review aims to present a perspective on the adipose tissue-cancer dynamics and provide an overview of the current 3D models used to reliably reproduce the adipose tissue-cancer interaction in vitro.

## Linked entities

- **Diseases:** cancer (MONDO:0004992), obesity (MONDO:0011122)

## Full-text entities

- **Genes:** EBF2 (EBF transcription factor 2) [NCBI Gene 64641] {aka COE2, EBF-2, O/E-3, OE-3}, ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216] {aka ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CYP2E1 (cytochrome P450 family 2 subfamily E member 1) [NCBI Gene 1571] {aka CPE1, CYP2E, P450-J, P450C2E}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, CFD (complement factor D) [NCBI Gene 1675] {aka ADIPSIN, ADN, DF, PFD}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, FST (follistatin) [NCBI Gene 10468] {aka FS}, FABP4 (fatty acid binding protein 4) [NCBI Gene 2167] {aka A-FABP, AFABP, ALBP, HEL-S-104, aP2}, ITGA5 (integrin subunit alpha 5) [NCBI Gene 3678] {aka CD49e, FNRA, VLA-5, VLA5A}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ADM (adrenomedullin) [NCBI Gene 133] {aka AM, PAMP}, RETN (resistin) [NCBI Gene 56729] {aka ADSF, FIZZ3, RENT, RETN1, RSTN, XCP1}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, INSR (insulin receptor) [NCBI Gene 3643] {aka CD220, HHF5}, LAMB2 (laminin subunit beta 2) [NCBI Gene 3913] {aka LAMS, NPHS5, PIERS}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, BMP7 (bone morphogenetic protein 7) [NCBI Gene 655] {aka OP-1}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, PRDM16 (PR/SET domain 16) [NCBI Gene 63976] {aka CMD1LL, KMT8F, LVNC8, MEL1, PFM13}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, EPDR1 (ependymin related 1) [NCBI Gene 54749] {aka EPDR, MERP-1, MERP1, UCC1}
- **Diseases:** colorectal and pancreatic cancer (MESH:D015179), hyperinsulinemia (MESH:D006946), tumorigenic (MESH:D002471), metastasis (MESH:D009362), breast, pancreatic, kidney, melanoma, and prostate cancer (MESH:C537243), insulin resistance (MESH:D007333), cardiovascular disease (MESH:D002318), breast cancer (MESH:D001943), SCAT (MESH:D018205), type 2 diabetes (MESH:D003924), necrosis (MESH:D009336), prostate cancer (MESH:D011471), inflammation (MESH:D007249), Tumour (MESH:D009369), carcinogenesis (MESH:D063646), stroke (MESH:D020521), Obesity (MESH:D009765), weight gain (MESH:D015430), liver steatosis (MESH:D005234), visceral adiposity (MESH:D007418), SGBS (MESH:C537340), metabolic disease (MESH:D008659)
- **Chemicals:** glycerol (MESH:D005990), GeltrexTM (-), fatty acid (MESH:D005227), agarose (MESH:D012685), lipid (MESH:D008055), palmitic acid (MESH:D019308), ATP (MESH:D000255), glucose (MESH:D005947), acetate (MESH:D000085), oxygen (MESH:D010100), pyruvate (MESH:D019289), polymers (MESH:D011108), TG (MESH:D014280), lactate (MESH:D019344), FFAs (MESH:D005230), hyaluronic acid (MESH:D006820)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** MCF10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598), SVF — Mus musculus (Mouse), Transformed cell line (CVCL_ZD83), LNCaP — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0395), 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), C4-2B — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_4784), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12953150/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12953150/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12953150/full.md

---
Source: https://tomesphere.com/paper/PMC12953150